Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights

Jan 13, 2025
by Keith Speights
My 3 Highest-Conviction Growth Stocks to Buy in 2025

Jan 10, 2025
by Keith Speights
Why TransMedics Group Stock Is Tanking Today

Jan 6, 2025
by Keith Speights
25 Top Dividend Stocks to Buy and Hold in 2025
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.